Agkistrodon contortrix phaeogaster
|Agkistrodon contortrix phaeogaster|
|Subspecies:||A. c. phaeogaster|
|Agkistrodon contortrix phaeogaster
Gloyd and Conant (1990) gives maximum total lengths of 990/723 mm for males/females, while mentioning that other sources give a maximum total length for this subspecies of 1,016 mm regardless of sex.
The venom of Agkistrodon contortrix phaeogaster is similar to the venoms produced by other species of the Agkistrodon genus. The exact ratio of toxins to each other varies among species and gender, as does the overall potency of the venom (the ratio of active toxins to other constituents of the venom). The venom is most potent between the late-spring and mid-summer months, this rise in toxicity commences 2–3 weeks prior to reaching peak toxicity. While the initial reduction of potency occurs over approximately one month, the snake's venom remains slightly more toxic throughout the late-summer months until beginning a slow descent to reach its original toxicity by mid-fall.
Danger to humans
The bite of the Osage copperhead is considered a medical emergency and the victim should be brought to a hospital immediately for the best prognosis (an ambulance should be called if the victim is alone as it is highly dangerous to drive after an envenomation.
The effects of the highly toxic venom present with a predictable course of symptoms until treatment is received. Immediate and severe pain, oozing of blood from the fang punctures, considerable edema, epistaxis, bleeding of the gums, marked hematuria, general petechiae, shock, renal failure and local necrosis. These effects are attributed to the various haemotoxins and necrotoxins contained in the venom. many other toxins are present in the venom in small quantities and are not clinically significant due to their extremely low concentrations.
CroFab antivenom has been used successfully to treat Osage copperhead bites although a lack of complete cross-tolerance requires careful administration and close supervision during the full course of treatment to ensure that the lowest effective dose is administered (a lower dose would not fully treat the envenomation, and a higher dose may be particularly dangerous to children, the elderly, and infirm adults). It is not uncommon for opiate/opioid narcotic analgesics (ex. morphine, fentanyl), muscle relaxerss (ex. diazepam, tizanidine, orphenadrine), and broad-spectrum antibiotics to be administered. A few days' supply of weaker analgesics and muscle relaxers may be prescribed for the patient to control pain after he or she returns home as the pain resolves completely within one to three days. Patients will also receive a prescription for an intensive antibiotic therapy, which much be taken until the supplies are depleted, giving the drug enough time to fully treat any opportunistic infections resulting from the bite-wounds or other transmission methods which the victim's weakened immune system cannot defend against. Failing to take the antibiotic/s until the prescription is depleted can cause the bacteria to "rebound" in a new form, possessing a greater resistance to antibiotics (MRSA developed through this process).
CroFab antivenom is effective in treating Agkistrodon contortrix phaeogaster bites, but it may cause severe anaphylactic shock and should not be used in any individuals to allergic to anything contained within the formula, unless the allergy is limited to non-lethal grievances such as rashes and itching. One other exception to this occurs when the envenomation is so severe that the victims doctor/doctors determine this risk of death from envenomation outweighs the risk of inducing anaphylaxis in a critically ill patient. There is a major shortage of CroFab in the U.S., and the vials which are available are exorbitantly priced, leading many doctors to negate the use of the antivenom in many patients whose bite resulted in extreme suffering but does not present any life-threatening symptoms (in these situations palliative care and symptomatic/supportive treatment approaches are utilized instead).
- List of crotaline species and subspecies
- Crotalinae by common name
- Crotalinae by taxonomic synonyms
- McDiarmid RW, Campbell JA, Touré T. 1999. Snake Species of the World: A Taxonomic and Geographic Reference, vol. 1. Herpetologists' League. 511 pp. ISBN 1-893777-00-6 (series). ISBN 1-893777-01-4 (volume).
- Gloyd HK, Conant R. 1990. Snakes of the Agkistrodon Complex: A Monographic Review. Society for the Study of Amphibians and Reptiles. 614 pp. 52 plates. LCCN 89-50342. ISBN 0-916984-20-6.
- "Agkistrodon contortrix phaeogaster". Integrated Taxonomic Information System. Retrieved 10 August 2007.
- Conant R. 1975. A Field Guide to Reptiles and Amphibians of Eastern and Central North America. Second Edition. First published in 1958. Houghton Mifflin Company Boston. 429 pp. 48 plates. ISBN 0-395-19979-4 (hc), ISBN 0-395-19977-8 (pb).
|Wikimedia Commons has media related to Agkistrodon contortrix.|